Clarity Pharmaceuticals Ltd (ASX:CU6)

Clarity Pharmaceuticals Revenue

In the fiscal year ending June 30, 2026, Clarity Pharmaceuticals had annual revenue of 10.53M AUD with 11.24% growth. Clarity Pharmaceuticals had revenue of 4.72M in the half year ending June 30, 2026, a decrease of -22.46%.

• Revenue: 10.53M
• Revenue Growth: +11.24%
• P/S Ratio: 74.43
• Revenue / Employee: 105.26K
• Employees: 100
• Market Cap: 783.47M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2026	10.53M	1.06M	11.24%
Jun 30, 2025	9.46M	-2.04M	-17.76%
Jun 30, 2024	11.51M	1.71M	17.41%
Jun 30, 2023	9.80M	3.34M	51.74%
Jun 30, 2022	6.46M	3.26M	102.06%

Data Source: S&P Global Market Intelligence Last updated: Aug 27, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 17, 2026

Data Sources Report a data error